Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy S Zheng

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Journal of Experimental Medicine|April 16, 2008
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune diseaseBhanu P Pappu, Anna Borodovsky, Timothy S Zheng, et al.
Scientific Reports|March 16, 2019
Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patientsLoubna Chadli, Britt Sotthewes, Kejie Li, et al.
The EMBO Journal|November 25, 2006
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regenerationMahasweta Girgenrath, Shawn Weng, Christine A Kostek, et al.
Circulation|April 8, 2009
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failureMohit Jain, Aniela Jakubowski, Lei Cui, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Journal of Experimental Medicine|April 16, 2008
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune diseaseBhanu P Pappu, Anna Borodovsky, Timothy S Zheng, et al.
Scientific Reports|March 16, 2019
Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patientsLoubna Chadli, Britt Sotthewes, Kejie Li, et al.
The EMBO Journal|November 25, 2006
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regenerationMahasweta Girgenrath, Shawn Weng, Christine A Kostek, et al.
Circulation|April 8, 2009
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failureMohit Jain, Aniela Jakubowski, Lei Cui, et al.
Pageof 4